FDA Staff Catches Off-Guard by Regulatory Shift Allowing Expanded E-Cigarette and Nicotine Pouch Sales in US

FDA's New Vaping Guidelines Spark Controversy and Confusion

The Food and Drug Administration (FDA) has implemented new guidelines that will allow more unauthorized electronic cigarettes and nicotine pouches onto the U.S. market, sparking controversy and confusion among agency officials and health researchers. The guidelines, posted online earlier this month, will allow companies to launch certain nicotine-based products before they've been fully vetted by regulators.

According to two FDA officials who spoke to The Associated Press on condition of anonymity, senior officials in the FDA's tobacco center were blindsided by the decision and only learned of it the night before the document was published. The officials, who were tasked with enforcing vaping regulations, were not consulted on the changes.

The new guidelines break with longstanding FDA policy, which required scientific verification of health benefits for smokers before any new products were introduced. The six-page memo, which has been met with internal confusion and criticism, has raised questions about the role of industry lobbyists and the influence of former FDA Commissioner Marty Makary, who resigned last week.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Makary, who had been under pressure from industry lobbyists, had been a vocal skeptic of the data showing declining underage vaping. Despite the influence campaign, vaping issues took a backseat at the FDA under Makary, with agency leaders intervening on rare occasions to block decisions that would have authorized new flavors.

The new guidelines, which bypassed a federally required period for public comment and revisions, are expected to allow for new flavors that had previously been blocked by regulators. While the FDA is supposed to publish a list of e-cigarettes and pouches that are not yet authorized but will be subject to "enforcement discretion," there is no public list of products that might qualify.

The FDA's new approach has been met with skepticism by health researchers, who point out that the agency has struggled to police the market for over a decade. Underage vaping among U.S. teenagers has fallen to its lowest level in more than 10 years, following the disruptions of the pandemic and new state and federal restrictions.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

The FDA's new guidelines are expected to allow for new flavors that had previously been blocked by regulators, but it remains to be seen whether the policy will be embraced by the vaping industry at large. Lobbyists for smaller companies say it's too early to tell whether the policy will be helpful or hurtful to their clients, but they fear being left behind.

Comparison of FDA's Authorized and Rejected Products

The FDA has authorized vaping products from five companies, while rejecting millions of other applications. Here is a comparison of the authorized and rejected products:

The FDA's new guidelines are expected to allow for new flavors that had previously been blocked by regulators, but it remains to be seen whether the policy will be effective in regulating the vaping industry.